PLoS ONE (Jan 2018)

Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.

  • Alfred L Yergey,
  • Paul S Blank,
  • Stephanie M Cologna,
  • Peter S Backlund,
  • Forbes D Porter,
  • Allan J Darling

DOI
https://doi.org/10.1371/journal.pone.0192424
Journal volume & issue
Vol. 13, no. 2
p. e0192424

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0175478.].